Precision Tissue Microablation Platform for Personalized Treatment
Legal Citation
Summary of the Inventive Concept
A next-generation tissue microablation system that integrates artificial intelligence, real-time feedback, and advanced laser technology to provide customized treatment protocols for skin and tissue conditions.
Background and Problem Solved
The original patent's limitations in terms of treatment pattern customization, real-time feedback, and optimal treatment outcomes are addressed by this new inventive concept, which leverages advancements in AI, imaging modalities, and laser technology to provide a more effective and personalized treatment solution.
Detailed Description of the Inventive Concept
The precision tissue microablation platform consists of a laser unit, a laser emitting device, and an AI-powered control system. The control system analyzes patient-specific skin and tissue characteristics to generate a customized treatment protocol, which is then executed by the laser emitting device to create a three-dimensional pattern of microchannels with varying depths and diameters. The system features a real-time feedback mechanism utilizing optical coherence tomography or other imaging modalities to monitor and adjust microchannel creation during treatment. Additionally, a novel laser beam splitter creates a fractional pattern of treatment radiation with dynamically adjustable parameters for optimal treatment outcomes.
Novelty and Inventive Step
The new claims introduce a paradigm shift in tissue microablation by incorporating AI-driven customization, real-time feedback, and advanced laser technology, which are not present in the original patent. The inventive concept's novelty lies in its ability to provide personalized treatment protocols, optimize treatment outcomes, and enable clinicians to visualize and simulate treatments prior to actual treatment.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different imaging modalities, such as ultrasound or MRI, to provide real-time feedback. Additionally, the system could be adapted for use in various medical specialties, such as dermatology, plastic surgery, or ophthalmology.
Potential Commercial Applications and Market
The precision tissue microablation platform has significant commercial potential in the medical aesthetics and healthcare industries, particularly in the treatment of skin and tissue conditions such as acne, rosacea, and skin cancer. The system's ability to provide personalized treatment protocols and optimize treatment outcomes could lead to increased adoption and market share in these industries.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical laser technology and tissue treatment systems, specifically focused on microablation techniques for dermatological and tissue modification procedures. Requires expertise in laser physics, medical device engineering, and tissue interaction technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with advanced degrees in bioengineering, optics, or medical technology, possessing knowledge of laser-tissue interactions, medical imaging, and treatment optimization techniques
Obviousness Rationale
A PHOSITA would recognize that the PTD's AI-driven customization and real-time feedback mechanisms represent predictable extensions of the source patent's foundational microablation technique. The core innovation of precise microchannel creation remains consistent, with the PTD merely introducing computational and adaptive technologies that are well-established in medical device design. The fundamental laser microablation principles from the source patent provide a clear technological foundation for these incremental improvements.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,810 |
|---|---|
| Title | System and methods of tissue microablation using fractional treatment patterns |
| Assignee(s) | LUMENIS BE LTD. |